MATERIALS AND METHODS:
A randomized, controlled trial was performed, assessing tissue thickness, pain, and foot pressures after fat grafting to the forefoot. Patients were randomized to receive either fat grafting or conservative management. Ultrasound-assessed tissue thickness, pedobarograph-assessed foot pressures, and the Manchester Foot Pain and Disability Index (MFPDI) 1 were obtained at baseline, 6mo, and 12mo visits. 18 patients (4 Male, 14 Female) comprised the treatment group, and 12 patients (4 Male, 8 Female) comprised the control group.
RESULTS:
Average age was 60 ± 8.7 years for the treatment group and 65.3 ± 8.5 for the control. Mean BMI was 26.8 ± 4.7 and 25.6 ± 6.1 in treatment and control groups respectively. 11 patients received bilateral injections with a mean volume of 4.8 ± 0.8mL and 4.7 ± 0.7mL in the right and left feet respectively. Mean follow-up time was 8.7 ± 6.2 months for the treatment group and 13.8 ± 4.2 months for controls (p=0.001). At 1 year, grafted subjects demonstrated improvements in foot function (p=0.022), pain (p=0.022), and work/leisure activities (p=0.021) with a significant increase in tissue thickness over the metatarsal heads (p<0.04) at 6mo but not at 12mo. However, controls experienced significant decreases in average metatarsal tissue thickness over the first 6mo (p<0.05), and in the thickness over the 3 rd metatarsal at 12mo (p=0.036), with most of the worsening occurring between the 6mo and 12mo time point (p=0.023). Foot pressures did not decrease after grafting. However, controls experienced increasing left foot pressure (P=0.011). When comparing the groups at 1 year, controls had significantly greater foot pressures and forces than patients receiving fat grafting (p<0.05).
CONCLUSION:
Despite decreasing tissue thickness over time, fat grafting for forefoot fat pad atrophy significantly improves pain and disability outcomes and prevents worsening foot forces and pressures. Pedal fat grafting is a safe, minimally invasive approach to treat fat pad atrophy with minimal downtime. Future analysis will reveal whether fat grafting has lasting efficacy. 
